Singular Genomics Systems (NASDAQ:OMIC) Price Target Cut to $0.85 by Analysts at The Goldman Sachs Group

Singular Genomics Systems (NASDAQ:OMIC – Get Free Report) had its price target dropped by equities research analysts at The Goldman Sachs Group from $0.95 to $0.85 in a note issued to investors on Monday, Benzinga reports. The firm currently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective suggests a potential […]

Related Keywords

Elin Glezer , ,Balyasny Asset Management ,Proshare Advisors ,Millennium Management ,Singular Genomics Systems Inc ,Singular Genomics Systems Company Profile ,Goldman Sachs Group ,Capital Management ,Singular Genomics Systems ,Get Free Report ,Genomics Systems Stock Down ,Genomics Systems ,Singular Genomics ,Asset Management ,Share Advisors ,Singular Genomics Systems Daily ,Nasdaq Omic ,Comic ,Medical ,Lower Price Target ,The Goldman Sachs Group Inc ,